Cargando…
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Natural killer (NK) cells are attractive within adoptive transfer settings in cancer immunotherapy due to their potential for allogeneic use; their alloreactivity is enhanced under conditions of killer immunoglobulin-like receptor (KIR) mismatch with human leukocyte antigen (HLA) ligands on cancer c...
Autores principales: | Lupo, Kyle B., Matosevic, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628161/ https://www.ncbi.nlm.nih.gov/pubmed/31163679 http://dx.doi.org/10.3390/cancers11060769 |
Ejemplares similares
-
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
por: Lupo, Kyle B., et al.
Publicado: (2020) -
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
por: Matosevic, Sandro
Publicado: (2018) -
Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
por: Chambers, Andrea M., et al.
Publicado: (2018) -
Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
por: Wang, Jiao, et al.
Publicado: (2018) -
Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
por: Chambers, Andrea M., et al.
Publicado: (2018)